Phase Ii evaluation of bisantrene in patients with advanced renal cell carcinoma
Evans, W.K.; Shepherd, F.A.; Blackstein, M.E.; Osoba, D.; Taylor, D.
Cancer Treatment Reports 69(6): 727-728
1985
ISSN/ISBN: 0361-5960 PMID: 4016779 Document Number: 250121
Document emailed within 1 workday
Related Documents
Elson, P.J.; Earhart, R.H.; Kvols, L.K.; Spiegel, R.; Keller, A.M.; Kies, M.S.; Davis, T.E.; Stevens, C.; Gumas, L.; Trump, D.L. 1987: Phase Ii studies of PCNU and bisantrene in advanced renal cell carcinoma Cancer Treatment Reports 71(3): 331-332Taylor, S.A.; Von Hoff, D.D.; Baker, L.H.; Balcerzak, S.P. 1984: Phase Ii clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study Cancer Treatment Reports 68(6): 919-920
Motzer, R.J.; Nanus, D.M.; O'Moore, P.; Scher, H.I.; Bajorin, D.F.; Reuter, V.; Tong, W.P.; Iversen, J.; Louison, C.; Albino, A.P. 1992: Phase II trial of suramin in patients with advanced renal cell carcinoma: treatment results, pharmacokinetics, and tumor growth factor expression Cancer Research 52(20): 5775-5779
Schulman, P.; Davis, R.B.; Rafla, S.; Green, M.; Henderson, E. 1984: Phase Ii trial of spirogermanium in advanced renal cell carcinoma: a Cancer and Leukemia Group B study Cancer Treatment Reports 68(10): 1305-1306
Cowan, J.D.; Surwit, E.A.; Alberts, D.S.; Boutselis, J.G.; Neilan, B.A. 1986: Phase II trial of bisantrene in previously treated patients with ovarian carcinoma: a Southwest Oncology Group Study Cancer Treatment Reports 70(3): 423-424
Tang, B.; Chi, Z.; Sheng, X.; Cui, C.; Si, L.; Kong, Y.; Li, S.; Mao, L.; Lian, B.; Wang, X.; Yan, X.; Guo, J. 2015: Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma Zhonghua Yi Xue Za Zhi 95(30): 2459-2461
Voravud, N.; Sriuranpong, V.; Lertsaguansinchai, P. 2000: Recombinant interferon-alpha 2b and megestrol acetate in patients with advanced renal cell carcinoma Journal of the Medical Association of Thailand 83(2): 123-128
Buter, J.; Sleijfer, D.T.; van der Graaf, W.T.; de Vries, E.G.; Willemse, P.H.; Mulder, N.H. 1993: A progress report on the outpatient treatment of patients with advanced renal cell carcinoma using subcutaneous recombinant interleukin-2 Seminars in Oncology 20(6 Suppl. 9): 16-21
Figlin, R.A. 2007: Temsirolimus for advanced renal cell carcinoma Clinical Advances in Hematology and Oncology: H&o 5(11): 893
Aulitzky, W.E.; Kaufmann, M. 2004: Immunotherapy for advanced renal cell carcinoma Der Urologe. Ausg. a 43(1): 85-92; Quiz 93
Fujita, T.; Fukushima, M. 1992: Interferon therapy for advanced renal cell carcinoma Hinyokika Kiyo. Acta Urologica Japonica 38(11): 1293-1298
Matsuyama, H.; Yamamoto, N.; Sakatoku, J.; Hara, Y.; Sacho, T.; Yasui, H.; Ichikawa, T.; Koshido, Y.; Hayasida, S.; Nagata, K. 1988: Clinical study of UFT in far-advanced renal cell carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(3): 527-530
Fiore, J.; Kemeny, N.; Raymond, V.; Young, C. 1986: Phase Ii trial of esorubicin in patients with advanced colorectal carcinoma Cancer Treatment Reports 70(10): 1241-1242
Tauer, K.; Kemeny, N.; Cheng, E.; Hollander, P.; Geller, N. 1986: Phase Ii trial of N-methylformamide in patients with advanced colorectal carcinoma Cancer Treatment Reports 70(6): 813-814
Shah, M.K.; St Marie, K.; Catalano, R.B.; Dierks, K.; Creech, R.H. 1985: Phase Ii study of 5-day infusion of vinblastine in patients with advanced ovarian carcinoma Cancer Treatment Reports 69(2): 229-230
Panetta, A.; Martoni, A.; Guaraldi, M.; Tamberi, S.; Casadio, M.; Lelli, G.; Pannuti, F. 1994: Combined chemo-immuno-hormonotherapy of advanced renal cell carcinoma Journal of ChemoTherapy 6(5): 349-353
Currie, V.E.; Camacho, F.; Wittes, R.; Young, C. 1980: Phase Ii evaluation of vindesine in patients with advanced breast cancer Cancer Treatment Reports 64(4-5): 693-695
Omachi, T.; Sakamoto, W.; Kishimoto, T.; Kawano, M.; Oyama, A.; Kamizuru, M.; Maekawa, M.; Hagihara, S.; Nakamura, K. 1992: A case of renal cyst associated with renal cell carcinoma--characteristics of intracystic fluid associated with renal cell carcinoma from Japanese reports Hinyokika Kiyo. Acta Urologica Japonica 38(3): 323-326
Huang, T.; Song, X-shuang.; Zhang, Z-wei. 2013: Efficacies of sorafenib plus interferon in advanced renal cell carcinoma: a report of 57 cases Zhonghua Yi Xue Za Zhi 93(24): 1903-1905
Wada, T.; Nishiyama, K.; Maeda, M.; Hara, S.; Tanaka, N.; Yasutomi, M.; Kurita, T. 1995: Combined chemoendocrine treatment with tegafur and tamoxifen for advanced renal cell carcinoma Anticancer Research 15(4): 1581-1584